Verisk heads into its third-quarter report with a peculiar setup. Last quarter, management delivered the growth rebound it had promised, then cautioned that the next three months would offer limited upside before a stronger finish to the year. The stock has since fallen sharply, which suggests the market heard the warning louder than the good news. The September quarter now has to show that the slowdown is a pause on the way to a stronger fourth quarter, and not the start of a longer stall.
Wall Street expects earnings of $1.92 per share on revenue of $806.8 million. That would be an 11.6% increase in earnings and 5.0% revenue growth from a year ago, a respectable but unspectacular pace. Sequentially, the numbers are telling: revenue is expected to be essentially flat with the prior quarter's $806.3 million, and earnings are projected below the $1.98 posted then. Analysts have clearly built management's caution into their models. For the full year, Verisk has reaffirmed its outlook for earnings of $7.45 to $7.75 per share on revenue of $3.19 billion to $3.24 billion. Consensus of $7.64 sits in the upper half of the earnings range, while the $3.22 billion revenue estimate is near the midpoint. That leaves the Street leaning on margins and a back-end-loaded year, which raises the stakes on any change in tone about the fourth quarter.
The operational story hinges on the split between subscriptions and transactions. Organic constant-currency revenue growth reaccelerated to 5.8% last quarter from a 4.7% trough, driven by subscription growth that improved to 8%. Transactional revenue remained negative but has narrowed steadily, from a decline of nearly 9% a year ago to about 4% last quarter. This quarter makes that recovery harder to sustain. Management noted that strong insurance-linked securities activity in the second quarter will not repeat, the hurricane season started slowly, and 2026 global catastrophe losses are tracking below $100 billion for the first time since 2020. Property and commercial property pricing is also softening, with lighter volumes expected through the second half. A modest backslide in transactional growth would be consistent with guidance. A sharp one would challenge the idea that the worst is behind the company.
Subscription momentum is where the bullish case has to hold. Holding growth at or near 8% would suggest Verisk's recurring base can absorb a weak insurance cycle. Investors should also look for further proof that AI is turning into revenue. Xact AI licensees rose roughly tenfold to about 7,000 since March, the Anthropic Claude connectors are already used by a top ten carrier, and Premium Audit AI showed early pricing gains at renewal. Updates on client adoption of the new Synergy Studio catastrophe platform and redesigned U.S. hurricane model, plus integration of the McKinsey Intelligence Services acquisition, would help show whether these launches are contributing. Management also flagged lengthy AI sales cycles tied to data governance and intellectual property negotiations, so any sign those are shortening would be welcome. The resolution of the federal work stoppage at the start of the quarter should remove a small headwind. Free cash flow, which jumped 58% last quarter, is another useful gauge of underlying quality.
The expectations backdrop is subdued. The shares have dropped 13.5% since the last report, trailing the S&P 500 by 17.5 percentage points. At about $188, the stock sits just above its 200-day moving average and in the lower half of its post-earnings range of roughly $162 to $226. Sentiment remains bearish, though somewhat less so than before the prior report. That combination lowers the bar for a reassuring print, but it also suggests investors want evidence rather than promises.
The central question is whether Verisk can show that its fourth-quarter acceleration is still on track. A quarter in line with consensus, steady subscription growth and a firm reaffirmation of the annual outlook would support the improving narrative from last quarter. A meaningful cut to the full-year range, or signs that weak insurance markets are dragging on subscriptions as well as transactions, would suggest the recent selloff was justified.